Biologics for Stricturing Crohn's Diseases
Observational · No treatment assigned · 1 site · Jinling Hospital, China
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: The Efficacy of Biologics for Stricturing Crohn's Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 16 to 65
- Any sex
Some of the main requirements, copied from the record:
- patients with stricturing Crohn's diseases
- no surgical indication
- patients with asymptomatic penetrating diseases
Plus 1 more requirement(s). There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 200 participants are expected to take part.
- Start date: 2021-01-01.
- Main results expected around 2024-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in China.
Main thing being measured
- clinical remission rate at 1 year (clinical remission rate at 1 year)
In the researchers’ words
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | The Efficacy of Biologics for Stricturing Crohn's Diseases |
| Lead sponsor | Jinling Hospital, China |
| Enrollment | 200 (estimated) |
| Start date | 2021-01-01 |
| Primary completion (est.) | 2024-01 |
| First posted | 2022-12-09 |
| Last updated | 2023-05-11 |
| Official title | The Clinical Outcomes of Patients With Stricturing Crohn's Diseases Received Biologics: a Prospective, Observative Study |
| ClinicalTrials.gov ID | NCT05645055 |
Interventions
- treat these patients with biologics (Other)
treat these patients with biologics
Full eligibility criteria (from the record)
Inclusion Criteria: * patients with stricturing Crohn's diseases * no surgical indication * patients with asymptomatic penetrating diseases * written consent acquired Exclusion Criteria: * patients with surgical indication * patients with symptomatic penetrating diseases * contraindication of biologics * anticipating other trial
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Department of General Surgery, Jinling hosptal,Medical School of Nanjing University | Nanjing, Jiangsu | China | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.